X-45151862-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_176819.4(DIPK2B):c.1092G>A(p.Lys364Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000788 in 1,210,112 control chromosomes in the GnomAD database, including 3 homozygotes. There are 248 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 2 hom., 123 hem., cov: 24)
Exomes 𝑓: 0.00048 ( 1 hom. 125 hem. )
Consequence
DIPK2B
NM_176819.4 synonymous
NM_176819.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00500
Genes affected
DIPK2B (HGNC:25866): (divergent protein kinase domain 2B) Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant X-45151862-C-T is Benign according to our data. Variant chrX-45151862-C-T is described in ClinVar as [Benign]. Clinvar id is 711138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.005 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIPK2B | NM_176819.4 | c.1092G>A | p.Lys364Lys | synonymous_variant | 5/5 | ENST00000398000.7 | NP_789789.2 | |
DIPK2B | XM_005272670.1 | c.918G>A | p.Lys306Lys | synonymous_variant | 4/4 | XP_005272727.1 | ||
DIPK2B | XM_006724559.1 | c.840G>A | p.Lys280Lys | synonymous_variant | 4/4 | XP_006724622.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIPK2B | ENST00000398000.7 | c.1092G>A | p.Lys364Lys | synonymous_variant | 5/5 | 5 | NM_176819.4 | ENSP00000381086.2 | ||
DIPK2B | ENST00000477281.1 | n.390G>A | non_coding_transcript_exon_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00374 AC: 422AN: 112729Hom.: 2 Cov.: 24 AF XY: 0.00347 AC XY: 121AN XY: 34871
GnomAD3 genomes
AF:
AC:
422
AN:
112729
Hom.:
Cov.:
24
AF XY:
AC XY:
121
AN XY:
34871
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000915 AC: 163AN: 178099Hom.: 0 AF XY: 0.000618 AC XY: 40AN XY: 64687
GnomAD3 exomes
AF:
AC:
163
AN:
178099
Hom.:
AF XY:
AC XY:
40
AN XY:
64687
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000481 AC: 528AN: 1097330Hom.: 1 Cov.: 31 AF XY: 0.000345 AC XY: 125AN XY: 362802
GnomAD4 exome
AF:
AC:
528
AN:
1097330
Hom.:
Cov.:
31
AF XY:
AC XY:
125
AN XY:
362802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00377 AC: 425AN: 112782Hom.: 2 Cov.: 24 AF XY: 0.00352 AC XY: 123AN XY: 34934
GnomAD4 genome
AF:
AC:
425
AN:
112782
Hom.:
Cov.:
24
AF XY:
AC XY:
123
AN XY:
34934
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 26, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
DIPK2B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at